Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
- 1 July 2023
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 29 (25) , 1975-1991
Abstract
Human health is significantly threatened by infectious diseases caused by viral infection. Over the years, there have been numerous virus epidemics worldwide, causing millions of deaths. Traditional antiviral medications have many problems, including poor solubility and antiviral resistance. Additionally, because different drug delivery methods have different biological barriers to overcome, the drug’s bioavailability will be significantly affected. Therefore, it is essential that researchers create more effective antiviral drugs. To serve as a guide for the future development of nanosized antiviral drugs with stronger and more precise therapeutic effects, research has been performed on nanotechnology in the field of antiviral therapy. This review summarizes the recent developments in antiviral nanopharmaceuticals with different delivery routes. Research on 7 typical viruses, including COVID-19, has been included in this review. After being loaded into nanoparticles, antiviral drugs can be delivered through several drug modes of delivery, overcoming biological barriers. Moreover, some nanoparticles themselves have the ability to combat infections, so they can be used in conjunction with antiviral medication. The use of nanoparticle medications through various routes of administration can result in their unique benefits. They can be capable of overcoming its limitations as well as retaining the advantages of this method of delivery. This will motivate researchers to conducted a new investigation on nanoparticle medicines from the standpoint of the route of administration in order to increase the practicability of antiviral medications.Keywords
Funding Information
- Guangxi Natural Science Foundation (2020GXNSFAA297178)
- Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards (guizhongzhongkai201703)
- Foundation of Key Laboratory of Trusted Software (kx201703)
This publication has 104 references indexed in Scilit:
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?Cold Spring Harbor Perspectives in Biology, 2017
- How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance ActivitiesThe AAPS Journal, 2017
- Control Measures for Human Respiratory Viral InfectionSeminars in Respiratory and Critical Care Medicine, 2016
- Approved Antiviral Drugs over the Past 50 YearsClinical Microbiology Reviews, 2016
- Synthesis of ZnO nanofibers by the electrospinning processMaterials Science in Semiconductor Processing, 2016
- Safety of Nanoparticles in MedicineCurrent Drug Targets, 2015
- The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human UseEuropean Journal of Cancer, 2013
- Overview of Nanomedicines Regulation in the European Union2012
- Viruses and endosome membrane dynamicsCurrent Opinion in Cell Biology, 2009
- Side effects of long-term oral antiviral therapy for hepatitis B #Hepatology, 2009